SCHEMBL30962750

SCHEMBL30962750

COc1nc(Nc2ccc(OC3CCN(C)CC3)c(C)c2)ncc1C(=O)Nc1c(Cl)ccc(O[Si](C)(C)C(C)(C)C)c1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TTK P33981 1/20 0.40
▸ SRC P12931 6/20 0.40
▸ LCK P06239 2/20 0.39
▸ JAK3 P52333 2/20 0.39
▸ KDR P35968 1/20 0.39
▸ TEK Q02763 1/20 0.39
▸ MAPK14 Q16539 1/20 0.39
▸ BRD4 O60885 5/20 0.39
▸ EGFR P00533 2/20 0.39
▸ SIK1 P57059 2/20 0.39
▸ SIK2 Q9H0K1 2/20 0.39
▸ SIK3 Q9Y2K2 2/20 0.39
▸ JAK2 O60674 1/20 0.38
▸ JAK1 P23458 1/20 0.38
▸ BRDT Q58F21 1/20 0.38
▸ FGFR1 P11362 1/20 0.38
▸ AXL P30530 1/20 0.38
▸ TYRO3 Q06418 1/20 0.38
▸ MERTK Q12866 1/20 0.38
▸ GPR6 P46095 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962685 0.97 SRC (0.38) TTKSRCLCKJAK3KDR
SCHEMBL30962908 0.91 WEE1 (0.43) SRCLCKJAK3KDRTEK
SCHEMBL30962681 0.89 TTK (0.43) TTKSRCLCKJAK3KDR
SCHEMBL30962922 0.86 WEE1 (0.44) SRCLCKJAK3KDRTEK
SCHEMBL30962719 0.86 PTK2 (0.40) SRCLCKJAK3KDRTEK
SCHEMBL30962930 0.86 SRC (0.46) TTKSRCLCKJAK3KDR
SCHEMBL30962929 0.86 SRC (0.46) TTKSRCLCKJAK3KDR
SCHEMBL30962942 0.86 SRC (0.41) TTKSRCLCKJAK3KDR
SCHEMBL30962674 0.86 SRC (0.41) TTKSRCLCKJAK3KDR
SCHEMBL30962817 0.84 LCK (0.43) TTKSRCLCKJAK3KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback